Cerebral Infarction (Brain Infarction) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024
- Transparency Market Research
Cerebral Infarction (Brain Infarction) Market: Overview
Brain infarction, also known as, cerebral infarction, is one of the chronic and life-threatening diseases. Cerebral infarction is one of the important type of ischemic stroke which is caused due to the development of blockage or clot in the blood vessel that carry blood to the brain. It is important to highlight that the cerebral infarction is different from brain hemorrhage. Since the disease condition arises suddenly, there is high possibility of death.
The major symptoms of the disease are identified with the help of brain monitoring technology. These symptoms primarily include light reaction, abnormal pupil dilation, loss of eye movement, slurrish speech, loss of energy and loss of movements and senses. The factors that propel the cerebral infarction include diabetes, atherosclerosis, obesity, smoking, blood pressure and others. The diagnosis of the disease is possible through MRI scanning, CT scans, and angiogram.
Cerebral Infarction (Brain Infarction) Market: Segmentation
The market for cerebral infarction is segmented on the basis of types of disease, such as, partial anterior circulation infarct (PACI), total anterior circulation infarct (TACI), posterior circulation infarct (POCI). Further, the market is also segmented on the basis of treatments, such as, anti-myocardial infarction drugs, thrombolytic drugs and others. Thrombolytic drugs such as tissue plasminogen activator (tPA) have proved their effectiveness in the management of the disease. Other treatments include treatment of the root cause of brain infarction, such as, anti-diabetes drugs, blood pressure drugs and others. Carotid endarterectomy is an important surgical treatment available for brain infarction management.
In addition to this, associated treatment includes physical therapy, exercises, speech therapy and angioplasty. Moreover, the market is also segmented on the basis of geography, such as, North America, Europe, Asia-Pacific and Rest of the World (RoW). At present, North America and Europe are the most prominent markets, owing to extensive research practices and growing prevalence of brain disorders. However, Asia-Pacific and some countries in RoW region are expected to show lucrative growth in upcoming period, owing to enhanced governmental support for research purposes and growth in awareness about neurological diseases.
Cerebral Infarction (Brain Infarction) Market: Trends and Outlook
The market of brain infarction is expected to show promising growth during the forecast period 2014 – 2020. This growth is driven by the various factors, such as, rising prevalence of brain disorders, rising prevalence of the diseases that augment cerebral infarction, extensive R&D practices, rising awareness and medical expenditure of the global population and technological advancements. Ischemic stroke is considered as the most important disease that causes brain infarction. According to the U.S. National Heart, Lung and Blood Institute (NHLBI), 1 in 59 or approximately 4.6 million people in the U.S. are suffering from cardiac stroke disease, which may lead to brain infarction. Out of this, approximately 62% of the cases occur with the patient with high blood pressure.
Thus, the rising prevalence of brain and other associated diseases is expected to propel the market of brain infarction. In addition to this, extensive R&D practices is another important driver of the market. As of 2014, there are number of products under pipeline studies, such as, CNTO-0007, epoetin alfa, AP-102, and others. Major restraints include high cost of R&D, diagnosis and treatment of the disease and limited technological penetration in certain region of the world, such as, Latin America and some of the African countries. These restraints may produce the hurdles to growth of the market.
Major players engaged in R&D and commercialization of products include CIMAB S.A., Johnson & Johnson, Aprogen, Inc., and Shin Nippon Biomedical Laboratories, Ltd. amongst others.
The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.
The study is a source of reliable data on:
- Key market segments and sub-segments
- Evolving market trends and dynamics
- Changing supply and demand scenarios
- Quantifying market opportunities through market sizing and market forecasting
- Tracking current trends/opportunities/challenges
- Competitive insights
- Opportunity mapping in terms of technological breakthroughs
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, Luxembourg)
- Eastern Europe (Poland, Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia and New Zealand)
- Middle East and Africa (GCC, Southern Africa, North Africa)
TMR estimates the market size of various sectors using a combination of available data on the number and revenue of companies within each sub-sector and tiers of companies. The basic components used to determine market size and forecast for a specific product area are not only limited to supply-side data, but are also related to demand, industry trends, and the economic outlook. All the above data points are utilized to generate a statistical model targeting the sector marketplace. More than 300 TMR analysts across the world integrate these elements into a framework to determine the subsector market size for a base year and then forecast growth within each market.
TMR regularly interviews technology and business professionals as an ongoing effort to track the latest developments within each sector. These continuous surveys are stratified by company size and industry segment and weighted to reflect the global market place. All data are collected on an ongoing effort through a structured questionnaire rolled over the web or conducted via telephones. This provides the TMR team opportunities to request for detailed question sets, complex skip patterns, and real-time calculations, which assists respondents in answering questions involving numbers and percentages. Respondents, who are interviewed as experts, are screened and qualified based on certain criteria in addition to their decision-making authority and the scope of activity within their organizations.
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Pharmaceutical
PharmaceuticalChinese Markets for Mental Illness Drugs
PharmaceuticalChinese Markets for Anti-Dermatomycosis Skin Drugs
PharmaceuticalChinese Markets for Incretion Drugs
PharmaceuticalChinese Markets for Hypertension Drugs
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017